{"company":{"id":3188444,"name":"Precigen","domain":"precigen.com","url":"https://alion.io/company/precigen"},"section":"news","answer":"Precigen: 8 headlines on record, 4 headlines in the last 90 days. Its story counts 5 milestones.","figures":[{"label":"Headlines","value":"8"},{"label":"In 90 days","value":"4"},{"label":"Milestones","value":"5"}],"blocks":[{"key":"news","title":"Headlines","source":"the outlets named on each headline, each story once","rows":8},{"key":"story","title":"Milestones","source":"Each milestone is dated by its source: registers, filings, the press","rows":5}],"news":[{"date":"2026-10-01","kind":"News","title":"Precigen (PGEN) Soars 6.3%: Is Further Upside Left in the Stock?","source":"YahooFinance","url":"https://finance.yahoo.com/markets/stocks/articles/precigen-pgen-soars-6-3-073500681.html"},{"date":"2026-09-30","kind":"News","title":"Precigen: The FDA's Platform Technology Designation And The Institutional Crossover Effect","source":"seekingalpha.com","url":"https://seekingalpha.com/article/4951004-precigen-the-fdas-platform-technology-designation-and-the-institutional-crossover-effect"},{"date":"2026-09-29","kind":"News","title":"Precigen (PGEN) Gets FDA Recognition. Can it Cut the Cost of Developing New Drugs?","source":"YahooFinance","url":"https://finance.yahoo.com/healthcare/articles/precigen-pgen-gets-fda-recognition-015839357.html"},{"date":"2026-09-18","kind":"News","title":"Precigen (PGEN) Stock May Be Fully Valued On Its Current Sales Base","source":"YahooFinance","url":"https://uk.finance.yahoo.com/news/precigen-pgen-stock-may-fully-101020828.html"},{"date":"2026-08-08","kind":"News","title":"Precigen: Has To Grow Into Its Valuation","source":"seekingalpha.com","url":"https://seekingalpha.com/article/4933659-precigen-has-to-grow-into-its-valuation"},{"date":"2025-12-03","kind":"News","title":"Precigen Stock Up 280% in a Year - Is FDA Approval Behind This Big New Investor Bet?","source":"The Motley Fool","url":"https://fool.com/coverage/filings/2025/12/02/precigen-stock-up-280-in-a-year-is-fda-approval-behind-this-big-new-investor-bet/"},{"date":"2025-08-15","kind":"News","title":"Precigen Announces Full FDA Approval of PAPZIMEOS (zopapogene imadenovec-drba), the First and Only Approved Therapy for the Treatment of Adults with Recurrent Respiratory Papillomatosis Newswise","source":"newswise.com","url":"https://newswise.com/articles/precigen-announces-full-fda-approval-of-papzimeos-zopapogene-imadenovec-drba-the-first-and-only-approved-therapy-for-the-treatment-of-adults-with-recurrent-respiratory-papillomatosis"},{"date":"2024-03-29","kind":"News","title":"Precigen adds to disease awareness calendar with day dedicated to recurrent respiratory papillomatosis","source":"fiercepharma.com","url":"https://fiercepharma.com/marketing/precigen-adds-disease-awareness-calendar-day-dedicated-recurrent-respiratory"}],"story":[{"title":"Went public NASDAQ: PGEN"},{"title":"Certified Precigen Announces Full FDA Approval of PAPZIMEOS (zopapogene imadenovec-drba), the First and Only Approved Therapy for the Treatment of Adults with… · newswise.com","url":"https://newswise.com/articles/precigen-announces-full-fda-approval-of-papzimeos-zopapogene-imadenovec-drba-the-first-and-only-approved-therapy-for-the-treatment-of-adults-with-recurrent-respiratory-papillomatosis"},{"title":"Raised a round Venture round $13M · SEC Form D","url":"https://www.sec.gov/Archives/edgar/data/1356090/000156761920021278/"},{"title":"Raised a round Venture round $35M · SEC Form D","url":"https://www.sec.gov/Archives/edgar/data/1356090/000156761920002772/"},{"title":"Raised a round Venture round $4.3M · SEC Form D","url":"https://www.sec.gov/Archives/edgar/data/1356090/000135609016000093/"}],"as_of":"2026-11-16","cite":"Precigen, News. Alion, Nov 16, 2026. https://alion.io/company/precigen/news","html_url":"https://alion.io/company/precigen/news","json_url":"https://alion.io/company/precigen/news.json","license":"CC BY-SA 4.0","meta":{"source":"Alion","generated_at":"2026-11-16T23:44:25Z"}}